Sandu Pharmaceuticals Ltd. - Research Center
524703 SANDUPHQ Group (X) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 34.26 | 32.99 | 30.57 | 34.93 | 24.20 |
| Operating profit | 1.18 | 1.19 | 1.34 | 1.54 | 0.58 |
| Interest | 0.04 | 0.05 | 0.03 | 0.09 | 0.18 |
| Gross profit | 1.23 | 1.40 | 1.35 | 1.50 | 0.57 |
| EPS (Rs) | 0.68 | 0.80 | 0.82 | 1.10 | 0.46 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 0.09 | 0.25 | 0.03 | 0.05 | 0.17 |
| Stock adjustment | 4.08 | 0.67 | -0.09 | -0.36 | -3.89 |
| Raw material | 4.59 | 4.90 | 6.20 | 7.99 | 5.27 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 5.07 | 5.16 | 4.18 | 4.73 | 3.56 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 19.34 | 21.07 | 18.94 | 21.03 | 18.68 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.26 | 0.25 | 0.27 | 0.27 | 0.28 |
| Taxation | 0.32 | 0.37 | 0.36 | 0.36 | -0.03 |
| Net profit / loss | 0.66 | 0.77 | 0.72 | 0.87 | 0.32 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 9.66 | 9.66 | 8.81 | 7.92 | 7.08 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 3.45 | 3.60 | 4.38 | 4.40 | 2.41 |
| GPM (%) | 3.59 | 4.20 | 4.40 | 4.29 | 2.36 |
| NPM (%) | 1.93 | 2.31 | 2.35 | 2.49 | 1.33 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis